Clinical Trial Detail

NCT ID NCT00717587
Title Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

renal cell carcinoma

Therapies

Sunitinib

Girentuximab

Motexafin gadolinium

Age Groups: adult

No variant requirements are available.